This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Drug of Abuse Testing Market

Market Insights on Drug of Abuse Testing covering sales outlook, demand forecast & up-to-date key trends

Drug of Abuse Testing Market by Product Type (Psychostimulants, Narcotic, Cannabinoids, Sedatives, Others), Technique (Immunoassay, Chromatography, Rapid Testing), End User (Hospitals, Diagnostics Laboratories, Forensic Laboratories & Others) & Region - Forecast to 2021 - 2031

Drug of Abuse Testing Market Snapshot

[185 Pages Report]  Newly released data by Future Market Insights (FMI) shows that the global drug of abuse testing market is projected to reach a valuation of US$ 1.5 Bn in 2021, with sales growing at above 5% CAGR through 2031.

Growing prevalence of opioid dependence among the geriatric population will fuel the demand for drug of abuse tsesting services. Besides this, sales of drug of abuse testing kits is expected to rise as a result of high demand for rapid and accurate drug testing equipment in forensic laboratories, hospitals, and senior citizen care centers.

Attribute

Details

Estimated Drug of Abuse Testing Market Size in 2021

US$ 1.5 Bn

Drug of Abuse Testing Market Value CAGR (2021-2031)

~5%

Customize this Report

Let us know your requirement to get
100% FREE customization

Drug of Abuse Testing Market Historic Sales Compared to 2021-2031 Forecast Outlook

Demand for drug of use testing equipment grew at a 6.02% CAGR between 2016 and 2020. Sales prospects were however dampened due to the outbreak of the novel COVID-19 pandemic. Disruptions in supply chains and inadequate availability of raw material hampered production and sales of drug of abuse testing equipment and tools.

Drug of Abuse Testing Market Download Report Brochure

However, with expedited vaccine drives and resumption of transport, recovery of the global drug of abuse testing market is on cards. FMI has projected sales of drug of abuse testing systems to increase by 6.40% year-over-year between 2020 and 2021. Rising awareness regarding high consumption of illicit drugs and overdose of prescribed medications will continue propelling demand for drug of abuse testing systems.

Apart from this, increasing preference for on-the-spot and disposable testing methods for rapid detection of drug abuse is expected to provide tailwinds to sales of drug of abuse testing tools.

To gain a competitive edge, leading players operating in the global drug of abuse testing market are providing training on the identification and handling of illicit drugs to law enforcement authorities through online services. Such initiatives are expected to create lucrative opportunities for drug of abuse testing players over the forecast period.

How is Advent of Drug Warning Systems Affecting Drug of Abuse Testing Industry?

Substance use disorders (SUDs) have emerged as a burden on society. In many parts of the world, annual surveys of drug and substance use in households, schools, and workplaces serve as one of the primary sources of information that indicate illicit drug use.

Increasing rate of prescription drug abuse are underpinning the importance of adequate testing and abuse detection. Research also has shown substantial comorbidity of SUDs with psychiatric disorders and physical health issues.

However, drug abuse mapping has its own challenges, which hinder prospects of research in substance abuse epidemiology to devise modern solutions for drug abuse epidemics. Further, it is imperative to pinpoint factors that link with individual vulnerabilities of SUDs such as genetics, social and environmental risk factors.

As deaths associated with fentanyl and other psychostimulants continue to rise and new psychoactive continue to emerge, methods of drug administration are also evolving. There has been a substantial rise in vaping of cannabis among teenagers and adolescents. Further, the COVID-19 outbreak has triggered drug overdoses and changes in drug use behaviors among homebound individuals.

To tackle these problems, the National Drug Early Warning System (NDEWS) is launched in the U.S. The new system incorporates real-time surveillance to detect early signs of potential drug abuse. It includes 18 sentinel sites that utilize modern surveillance methods and gather data in a rapid, secure, and timely manner.

Data collection in real-time will provide a comprehensive characterization of drug use and the availability of on-ground epidemiologic investigations in high-priority areas of concern. Such developments and implementation of novel drug of abuse testing guidelines are expected to propel sales of drug of abuse testing over the assessment period.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

How is Increasing Incidence of Drug Abuse among the Elderly Spurring Demand for Drug of Abuse Testing?

Chronic pain is more common and complicated in the geriatric population. According to the National Institute of Health (NIH), up to 80% of patients with cancer and 77% with heart disease have reported persistent pain. Patients are often prescribed opioid medications for pain management. However, regular opioid usage results in addiction, which also compels patients to resort to cheaper drugs.

Besides this, rising adoption of recreational marijuana for chronic pain management is also fueling addiction problems. Ongoing research and medical trials indicate that medical marijuana can improve sleep hygiene, malnutrition, depression, and other side effects of cancer treatment.

Regular usage of marijuana for medical or recreational purposes has also been linked to depression, impaired memory, adverse cardiovascular functions, altered judgment, and motor skills in the geriatric population. Cannabinoids can also interact with other prescription drugs and complicate pre-existing health issues in older adults.

As incidence of opioid dependence continues to rise, healthcare professionals and other medical institutes are running regular tests and screening of the elderly to diagnose signs of drug abuse at an early stage. This is expected to spur demand for drug of abuse testing tools and equipment in hospitals and diagnostics 

Country-wise Insights

What will drive the U.S. Drug of Abuse Testing Market?

Rising prevalence of opioid dependence in the U.S. is expected to continue boosting demand for drug of abuse testing tools and equipment. Substance abuse rates during the COVID-19 pandemic have grown substantially in the country, with more individuals getting dependent on cannabinoids for stress and anxiety relief.

As per the National Centre for Drug Abuse Statistics, 53 million individuals over the age of 12 have used illegal drugs or have misused prescription drugs in 2020. Commonly abused prescribed stimulants include Adderall, Modafinil, Ritalin, and Concerta. Non-sanctioned use of these drugs leads to drug abuse.

In response to the growing drug dependence among individuals in the U.S., manufacturers are launching effective and accurate drug of abuse testing kits. Along with novel product launches, key manufacturers are also collaborating with research institutes and local authorities to spread awareness regarding drug abuse. This is expected to propel sales of drug of abuse testing in the U.S. over the forecast period.

Will the U.K. Drug of Abuse Testing Market Exhibit Consistent Growth?

The Centre for Social Justice determined that snowballing drug addiction in the U.K. has made it the “addiction capital of Europe”. Increasing usage of legal substances, mainly alcohol, and the usage of Class A drugs comprising heroin, meth, cocaine, and other hallucinogens is compelling authorities to launch drug testing protocols.

Causalities due to substance abuse in the U.K. is affecting users, as well as communities they belong to, and the society as a whole. Due to increasing costs of lab-based screening tests, hospitals and drug management authorities are adopting on-the-spot testing kits. Manufacturers are developing easy-to-use and disposable drug of abuse testing systems to cater to high demand from hospitals and forensic labs.

The aforementioned factors are anticipated to offer lucrative opportunities for drug of abuse testing market players operating in Europe, placing the U.K. as an attractive pocket for sales in the forthcoming years.

Why is China Drug of Abuse Testing Market Considered Lucrative?

Consistent usage of illicit drugs can lead to adverse mental and physical health disorders including cardiovascular diseases, fatal overdose, intentional or unintentional injuries, and even crime.

These issues later progress into clinical and social severity, difficulty in management of daily activities, morbidity, and non-adherence to treatment. This, coupled with the growing prevalence of alcohol dependence in China is compelling authorities to increase testing of drug abuse among citizens.

Sales of drug of abuse testing systems in China are expected to grow at a steady pace. The presence of key manufacturers, along with rapid expansion of the healthcare sector and easy availability of raw material are some factors expected to augment growth of the market through 2031.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-wise Insights

Drug of Abuse Testing for Cannabinoids to Gain Momentum

As per National Centre for Drug Abuse Statistics, approximately 16.9% of American adults currently use marijuana. Marijuana is widely accepted as a recreational drug and is considered "less risky" than other substances such as alcohol, tobacco, and painkillers.

Growing popularity of cannabinoids can be attributed to their acceptance in modern society. As it is considered "less harmful", there has been less incidence of marijuana overdose. However, in some countries, consumption of marijuana is illegal even for recreational purposes. Marijuana addiction is rare, although overuse can still result in dementia, cardiovascular issues, and breathing disorders.

Owing to these factors, FMI has projected sales of drug for abuse testing for cannabinoids to continue gaining momentum through 2031.

Immunoassays to Remain Highly Sought-After Drug of Abuse Testing Technique

Demand for immunoassays is expected to rise at a steady pace over the forecast period owing to rising preference towards on-the-spot testing and higher adoption of disposable blood testing devices.

This technique is commonly used for drug testing in urine. Immunoassays are generally used for initial screening. Common formats of immunoassays used for drugs of abuse comprise EMIT (enzyme multiplied immunoassay technique), CEDIA (cloned enzyme donor immunoassays technique), and KIMS (kinetic interaction of microparticle in solution).

Sales of Drug of Abuse Testing in Forensic Laboratories to Continue Rising

Forensic drug chemistry is applied to identify illegal substances in the criminal justice system. Chemists use characteristics such as interaction of atoms and molecules, chemical signature, and unique to only those substances.

Forensic chemistry covers aspects including drugs, explosives, and poisons. As per FMI, forensic laboratories are projected to remain the prominent end-user of drug of abuse testing. Growing demand for accurate and proper testing of individuals consuming illicit drugs and retailing illegal substances is expected to propel sales of drug of abuse testing in forensic laboratories over the assessment period.

Competitive Landscape

Top 5 players operating in the global drug of abuse testing market comprise Quest Diagnostics, Roche Holding AG, Siemens AG (Siemens Healthineers), and Thermo Fisher Scientific, Inc. are the top players accounting for maximum sales in the market.

Leading players operating in the global drug of abuse testing market are focusing on research and development to launch novel testing tools that are more effective and accurate. Apart from this, players are investing in mergers, acquisitions, collaborations, and partnerships to expand their global footprint.

For instance, Abbott Laboratories partnered with Intoximeters in August 2019, allowing the latter to market Abbott's SoToxaTM Mobile Test System. This is a handheld solution for oral fluid roadside testing. It has been designed to allow rapid detection of recent drug use.

Scope of Report

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2016-2020

Market Analysis

USD Million for Value

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa

Key Countries Covered

US, Canada, Germany, U.K., France, Italy, Spain, Russia, China, Japan, South Korea, India, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC Countries, Turkey, Northern Africa, and South Africa

Key Segments Covered

Drug, Technique, End User, and Regions

Key Companies Profiled

  • Quest Diagnostics
  • Roche Holding AG
  • Thermo Fisher Scientific, Inc.
  • Siemens AG (Siemens Healthineers)
  • Abbott Laboratories (Alere, Inc.)
  • Shimadzu Corporation
  • Express Diagnostics International Inc.
  • Drägerwerk AG & Co. KGaA
  • Laboratory Corporation of America Holdings.

Report Coverage

Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Drug of Abuse Testing Market by Category

By Drug Type:

  • Psychostimulants
  • Narcotic
  • Cannabinoids
  • Sedatives
  • Others

By Technique:

  • Immunoassay
  • Chromatography
  • Rapid Testing

By End User:

  • Hospitals
  • Diagnostics Laboratories
  • Forensic Laboratories
  • Others

By Region:                                                                                                     

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa

Frequently Asked Questions

The global drug of abuse testing market is expected to reach as valuation of US$ 1559.5 Mn in 2021.

Demand for drug of abuse testing systems grew at a 6.02% CAGR between 2026 and 2020.

Rising preference for on-spot and disposable testing tools, along with increasing dependence on prescription drugs among the elderly for pain managements are some trends that are boosting sales of drug of abuse testing systems.

Quest Diagnostics, Roche Holding AG, Thermo Fisher Scientific, Inc., Siemens AG (Siemens Healthineers), Abbott Laboratories (Alere, Inc.), Shimadzu Corporation, Express Diagnostics International Inc., Drägerwerk AG & Co. KGaA, and Laboratory Corporation of America Holdings are among key players operating in the drug of abuse testing market.

Sales of drug of abuse testing in North America are expected to grow at a 4.56% CAGR over the assessment period.

Leading players operating in the global drug of abuse testing market are anticipated to hold 50-55% of the total market share over the assessment period.

The dug of abuse testing market is expected to expand at a 5.19% CAGR over the forecast period.

Japan is expected to hold 7%, while South Korea is anticipated to account for less than 1% of the total drug of abuse testing market share.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Market Background

    3.1. Macro-Economic Factors

        3.1.1. Growing Impact of Drug and Alcohol Abuse on Public Health

        3.1.2. Rise in Law Enforcement Spending for Illicit Drug Interdiction

    3.2. Forecast Factors - Relevance & Impact

        3.2.1. Rise in Number of Clinical Laboratories offering Drugs of Abuse Testing Services

        3.2.2. Awareness Initiatives from the Manufacturers

        3.2.3. Rising R&D investments

        3.2.4. Drug Abuse Testing Regulation

    3.3. Market Dynamics

        3.3.1. Drivers

        3.3.2. Restraints

        3.3.3. Opportunity Analysis

4. Global Drug of Abuse Testing Market Demand (Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

    4.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    4.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Drug of Abuse Testing Market Analysis 2016-2020 and Forecast 2021-2031, by Drug Type 

    5.1. Introduction / Key Findings

    5.2. Historical Market Size (US$ Mn) Analysis By Drug Type, 2016–2020

    5.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Type, 2021-2031

        5.3.1. Psychostimulants

        5.3.2. Narcotics

        5.3.3. Cannabinoids

        5.3.4. Sedatives

        5.3.5. Others

    5.4. Market Attractiveness Analysis By Drug Type

6. Global Drug of Abuse Testing Market Analysis 2016-2020 and Forecast 2021-2031, by Technique 

    6.1. Introduction / Key Findings

    6.2. Historical Market Size (US$ Mn) Analysis By Technique, 2016–2020

    6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technique, 2021-2031

        6.3.1. Immunoassay

        6.3.2. Chromatography

        6.3.3. Rapid Testing

    6.4. Market Attractiveness Analysis By Technique

7. Global Drug of Abuse Testing Market Analysis 2016-2020 and Forecast 2021-2031, by End User

    7.1. Introduction / Key Findings

    7.2. Historical Market Size (US$ Mn) Analysis By End User, 2016–2020

    7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2021-2031

        7.3.1. Hospitals

        7.3.2. Diagnostics Laboratories

        7.3.3. Forensic Laboratories

        7.3.4. Others

    7.4. Market Attractiveness Analysis By End User

8. Global Drug of Abuse Testing Market Analysis 2016-2020 and Forecast 2021-2031, by Region

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Region, 2016–2020

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031

        8.3.1. North America

        8.3.2. Latin America

        8.3.3. Western Europe

        8.3.4. Eastern Europe

        8.3.5. APEJ

        8.3.6. Japan

        8.3.7. MEA

    8.4. Market Attractiveness Analysis By Region

9. North America Drug of Abuse Testing Market Analysis 2016-2020 and Forecast 2021-2031

    9.1. Introduction

    9.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031

        9.3.1.  By Country

            9.3.1.1. U.S.

            9.3.1.2. Canada

        9.3.2. By Drug Type

        9.3.3. By Technique

        9.3.4. By End User

    9.4. Market Attractiveness Analysis

        9.4.1. By Country

        9.4.2. By Drug Type

        9.4.3. By Technique

        9.4.4. By End User

    9.5. Key Market Participants - Intensity Mapping

    9.6. Drivers and Restraints - Impact Analysis

10. Latin America Drug of Abuse Testing Market Analysis 2016-2020 and Forecast 2021-2031

    10.1. Introduction

    10.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020

    10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031

        10.3.1.  By Country

            10.3.1.1. Brazil

            10.3.1.2. Mexico

            10.3.1.3. Rest of Latin America

        10.3.2. By Drug Type

        10.3.3. By Technique

        10.3.4. By End User

    10.4. Market Attractiveness Analysis

        10.4.1. By Country

        10.4.2. By Drug Type

        10.4.3. By Technique

        10.4.4. By End User

    10.5. Key Market Participants - Intensity Mapping

    10.6. Drivers and Restraints - Impact Analysis

11. Western Europe Drug of Abuse Testing Market Analysis 2016-2020 and Forecast 2021-2031

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031

        11.3.1.  By Country

            11.3.1.1. Germany

            11.3.1.2. UK

            11.3.1.3. France

            11.3.1.4. Spain

            11.3.1.5. Italy

            11.3.1.6. Nordic Countries

            11.3.1.7. Rest of WE

        11.3.2. By Drug Type

        11.3.3. By Technique

        11.3.4. By End User

    11.4. Market Attractiveness Analysis

        11.4.1. By Country

        11.4.2. By Drug Type

        11.4.3. By Technique

        11.4.4. By End User

    11.5. Key Market Participants - Intensity Mapping

    11.6. Drivers and Restraints - Impact Analysis

12. Eastern Europe Drug of Abuse Testing Market Analysis 2016-2020 and Forecast 2021-2031

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031

        12.3.1.  By Country

            12.3.1.1. Russia

            12.3.1.2. Poland

            12.3.1.3. Rest of EE

        12.3.2. By Drug Type

        12.3.3. By Technique

        12.3.4. By End User

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Drug Type

        12.4.3. By Technique

        12.4.4. By End User

    12.5. Key Market Participants - Intensity Mapping

    12.6. Drivers and Restraints - Impact Analysis

13. APEJ Drug of Abuse Testing Market Analysis 2016-2020 and Forecast 2021-2031

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031

        13.3.1.  By Country

            13.3.1.1. China

            13.3.1.2. India

            13.3.1.3. Australia & NZ

            13.3.1.4. ASEAN

            13.3.1.5. Rest of APEJ

        13.3.2. By Drug Type

        13.3.3. By Technique

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Drug Type

        13.4.3. By Technique

        13.4.4. By End User

    13.5. Key Market Participants - Intensity Mapping

    13.6. Drivers and Restraints - Impact Analysis

14. Japan Drug of Abuse Testing Market Analysis 2016-2020 and Forecast 2021-2031

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031

        14.3.1.  By Country

            14.3.1.1. Japan

        14.3.2. By Drug Type

        14.3.3. By Technique

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Drug Type

        14.4.3. By Technique

        14.4.4. By End User

    14.5. Key Market Participants - Intensity Mapping

    14.6. Drivers and Restraints - Impact Analysis

15. Middle East and Africa Drug of Abuse Testing Market Analysis 2016-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2016–2020

    15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2021-2031

        15.3.1.  By Country

            15.3.1.1. GCC Countries

            15.3.1.2. South Africa

            15.3.1.3. Rest of MEA

        15.3.2. By Drug Type

        15.3.3. By Technique

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Drug Type

        15.4.3. By Technique

        15.4.4. By End User

    15.5. Key Market Participants - Intensity Mapping

    15.6. Drivers and Restraints - Impact Analysis

16. Competition Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Competition Deep Dive (Tentative List)

        16.3.1. Quest Diagnostics

            16.3.1.1. Overview

            16.3.1.2. Service Portfolio

            16.3.1.3. Profitability by Market Segments (Service/Channel/Region)

            16.3.1.4. Sales Footprint

            16.3.1.5. Strategy Overview

                16.3.1.5.1. Marketing Strategy

                16.3.1.5.2. Service Strategy

                16.3.1.5.3. Channel Strategy

        16.3.2. F. Hoffmann-La Roche Ltd

            16.3.2.1. Overview

            16.3.2.2. Service Portfolio

            16.3.2.3. Profitability by Market Segments (Service/Channel/Region)

            16.3.2.4. Sales Footprint

            16.3.2.5. Strategy Overview

                16.3.2.5.1. Marketing Strategy

                16.3.2.5.2. Service Strategy

                16.3.2.5.3. Channel Strategy

        16.3.3. Siemens AG (Siemens Healthineers)

            16.3.3.1. Overview

            16.3.3.2. Service Portfolio

            16.3.3.3. Profitability by Market Segments (Service/Channel/Region)

            16.3.3.4. Sales Footprint

            16.3.3.5. Strategy Overview

                16.3.3.5.1. Marketing Strategy

                16.3.3.5.2. Service Strategy

                16.3.3.5.3. Channel Strategy

        16.3.4. Thermo Fisher Scientific, Inc.

            16.3.4.1. Overview

            16.3.4.2. Service Portfolio

            16.3.4.3. Profitability by Market Segments (Service/Channel/Region)

            16.3.4.4. Sales Footprint

            16.3.4.5. Strategy Overview

                16.3.4.5.1. Marketing Strategy

                16.3.4.5.2. Service Strategy

                16.3.4.5.3. Channel Strategy

        16.3.5. Abbott Laboratories (Alere, Inc.)

            16.3.5.1. Overview

            16.3.5.2. Service Portfolio

            16.3.5.3. Profitability by Market Segments (Service/Channel/Region)

            16.3.5.4. Sales Footprint

            16.3.5.5. Strategy Overview

                16.3.5.5.1. Marketing Strategy

                16.3.5.5.2. Service Strategy

                16.3.5.5.3. Channel Strategy

        16.3.6. Shimadzu Corporation

            16.3.6.1. Overview

            16.3.6.2. Service Portfolio

            16.3.6.3. Profitability by Market Segments (Service/Channel/Region)

            16.3.6.4. Sales Footprint

            16.3.6.5. Strategy Overview

                16.3.6.5.1. Marketing Strategy

                16.3.6.5.2. Service Strategy

                16.3.6.5.3. Channel Strategy

        16.3.7. Laboratory Corporation of America Holdings

            16.3.7.1. Overview

            16.3.7.2. Service Portfolio

            16.3.7.3. Profitability by Market Segments (Service/Channel/Region)

            16.3.7.4. Sales Footprint

            16.3.7.5. Strategy Overview

                16.3.7.5.1. Marketing Strategy

                16.3.7.5.2. Service Strategy

                16.3.7.5.3. Channel Strategy

        16.3.8. Drägerwerk AG & Co. KGaA

            16.3.8.1. Overview

            16.3.8.2. Service Portfolio

            16.3.8.3. Profitability by Market Segments (Service/Channel/Region)

            16.3.8.4. Sales Footprint

            16.3.8.5. Strategy Overview

                16.3.8.5.1. Marketing Strategy

                16.3.8.5.2. Service Strategy

                16.3.8.5.3. Channel Strategy

        16.3.9. Express Diagnostics International Inc.

            16.3.9.1. Overview

            16.3.9.2. Service Portfolio

            16.3.9.3. Profitability by Market Segments (Service/Channel/Region)

            16.3.9.4. Sales Footprint

            16.3.9.5. Strategy Overview

                16.3.9.5.1. Marketing Strategy

                16.3.9.5.2. Service Strategy

                16.3.9.5.3. Channel Strategy

17. Assumptions and Acronyms Used

18. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Drug of Abuse Testing Market Value (US$ Mn) Growth Comparison

Table 02: Global Drug of Abuse Testing Market Value (US$ Mn) Analysis and Opportunity Assessment 2021–2031, By Region 

Table 03: Global Drug of Abuse Testing Market Value (US$ Mn) Analysis and Opportunity Assessment 2021–2031, By Drug Type 

Table 04: Global Drug of Abuse Testing Market Value (US$ Mn) Analysis and Opportunity Assessment 2021–2031, By Technique 

Table 05: Global Drug of Abuse Testing Market Value (US$ Mn) Analysis and Opportunity Assessment 2021–2031, By End User 

Table 06: North America Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 07: North America Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Drug Type

Table 08: North America Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Technique

Table 09: North America Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By End User 

Table 10: Latin America Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 11: Latin America Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Drug Type

Table 12: Latin America Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Technique

Table 13: Latin America Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By End User 

Table 14: Western Europe Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 15: Western Europe Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Drug Type

Table 16: Western Europe Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Technique

Table 17: Western Europe Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By End User 

Table 18: Eastern Europe Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 19: Eastern Europe Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Drug Type

Table 20: Eastern Europe Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Technique

Table 21: Eastern Europe Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By End User 

Table 22: APEJ Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 23: APEJ Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Drug Type

Table 24: APEJ Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Technique

Table 25: APEJ Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By End User 

Table 26: Japan Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 27: Japan Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Drug Type

Table 28: Japan Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Technique

Table 29: Japan Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By End User 

Table 30: MEA Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Country

Table 31: MEA Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Drug Type

Table 32: MEA Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By Technique

Table 33: MEA Drug of Abuse Testing Market Value (US$ Mn) Analysis 2016-2020 and Forecast 2021–2031, By End User 

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Drug of Abuse Testing Market Value (US$ Mn), 2021-2031

Figure 02: Global Drug of Abuse Testing Market Value Share By Drug Type 2021 (E)

Figure 03: Global Drug of Abuse Testing Market  Value Share By Technique 2021 (E)

Figure 04: Global Drug of Abuse Testing Market  Value Share By End User 2021 (E)

Figure 05: Global Drug of Abuse Testing Market  Value Share By Region 2021 (E)

Figure 06: Global Drug of Abuse Testing Market Value Analysis (US$ Mn), 2016-2020

Figure 07: Global Drug of Abuse Testing Market Value Forecast (US$ Mn), 2021-2031

Figure 08: Global Drug of Abuse Testing Market Absolute $ Opportunity, 2021 - 2031

Figure 09: Comparison January 2018 and October 2021, Y-o-Y Forecast

Figure 10: Global Drug of Abuse Testing Market Share Analysis (%), By Region, 2021 & 2031

Figure 11: Global Drug of Abuse Testing Market Y-o-Y Analysis (%), By Region, 2021-2031

Figure 12: Global Drug of Abuse Testing Market Attractiveness Analysis by Region, 2021-2031

Figure 13: Global Drug of Abuse Testing Market Share Analysis (%), By Drug Type, 2021 & 2031

Figure 14: Global Drug of Abuse Testing Market Y-o-Y Analysis (%), By Drug Type, 2021-2031

Figure 15: Global Drug of Abuse Testing Market Attractiveness Analysis by Drug Type, 2021-2031

Figure 16: Global Drug of Abuse Testing Market Share Analysis (%), By Technique, 2021 & 2031

Figure 17: Global Drug of Abuse Testing Market Y-o-Y Analysis (%), By Technique, 2021-2031

Figure 18: Global Drug of Abuse Testing Market Attractiveness Analysis by Technique, 2021-2031

Figure 19: Global Drug of Abuse Testing Market Share Analysis (%), By End User, 2021 & 2031

Figure 20: Global Drug of Abuse Testing Market Y-o-Y Analysis (%), By End User, 2021-2031

Figure 21: Global Drug of Abuse Testing Market Attractiveness Analysis by End User, 2021-2031

Figure 22: North America Drug of Abuse Testing Market Value Share, By Drug Type (2021 E)

Figure 23: North America Drug of Abuse Testing Market Value Share, By Technique (2021 E)

Figure 24: North America Drug of Abuse Testing Market Value Share, By End User (2021 E)

Figure 25: North America Drug of Abuse Testing Market Value Share, By Country (2021 E)

Figure 26: North America Drug of Abuse Testing Market Value Analysis (US$ Mn), 2016-2020

Figure 27: North America Drug of Abuse Testing Market Value Forecast (US$ Mn), 2021-2031

Figure 28: North America Drug of Abuse Testing Market Attractiveness Analysis by Drug Type, 2021-2031

Figure 29: North America Drug of Abuse Testing Market Attractiveness Analysis by Technique, 2021-2031

Figure 30: North America Drug of Abuse Testing Market Attractiveness Analysis by End User, 2021-2031

Figure 31: North America Drug of Abuse Testing Market Attractiveness Analysis by Country, 2021-2031

Figure 32: Latin America Drug of Abuse Testing Market Value Share, By Drug Type (2021 E)

Figure 33: Latin America Drug of Abuse Testing Market Value Share, By Technique (2021 E)

Figure 34: Latin America Drug of Abuse Testing Market Value Share, By End User (2021 E)

Figure 35: Latin America Drug of Abuse Testing Market Value Share, By Country (2021 E)

Figure 36: Latin America Drug of Abuse Testing Market Value Analysis (US$ Mn), 2016-2020

Figure 37: Latin America Drug of Abuse Testing Market Value Forecast (US$ Mn), 2021-2031

Figure 38: Latin America Drug of Abuse Testing Market Attractiveness Analysis by Drug Type, 2021-2031

Figure 39: Latin America Drug of Abuse Testing Market Attractiveness Analysis by Technique, 2021-2031

Figure 40: Latin America Drug of Abuse Testing Market Attractiveness Analysis by End User, 2021-2031

Figure 41: Latin America Drug of Abuse Testing Market Attractiveness Analysis by Country, 2021-2031

Figure 42: Western Europe Drug of Abuse Testing Market Value Share, By Drug Type (2021 E)

Figure 43: Western Europe Drug of Abuse Testing Market Value Share, By Technique (2021 E)

Figure 44: Western Europe Drug of Abuse Testing Market Value Share, By End User (2021 E)

Figure 45: Western Europe Drug of Abuse Testing Market Value Share, By Country (2021 E)

Figure 46: Western Europe Drug of Abuse Testing Market Value Analysis (US$ Mn), 2016-2020

Figure 47: Western Europe Drug of Abuse Testing Market Value Forecast (US$ Mn), 2021-2031

Figure 48: Western Europe Drug of Abuse Testing Market Attractiveness Analysis by Drug Type, 2021-2031

Figure 49: Western Europe Drug of Abuse Testing Market Attractiveness Analysis by Technique, 2021-2031

Figure 50: Western Europe Drug of Abuse Testing Market Attractiveness Analysis by End User, 2021-2031

Figure 51: Western Europe Drug of Abuse Testing Market Attractiveness Analysis by Country, 2021-2031

Figure 52: Eastern Europe Drug of Abuse Testing Market Value Share, By Drug Type (2021 E)

Figure 53: Eastern Europe Drug of Abuse Testing Market Value Share, By Technique (2021 E)

Figure 54: Eastern Europe Drug of Abuse Testing Market Value Share, By End User (2021 E)

Figure 55: Eastern Europe Drug of Abuse Testing Market Value Share, By Country (2021 E)

Figure 56: Eastern Europe Drug of Abuse Testing Market Value Analysis (US$ Mn), 2016-2020

Figure 57: Eastern Europe Drug of Abuse Testing Market Value Forecast (US$ Mn), 2021-2031

Figure 58: Eastern Europe Drug of Abuse Testing Market Attractiveness Analysis by Drug Type, 2021-2031

Figure 59: Eastern Europe Drug of Abuse Testing Market Attractiveness Analysis by Technique, 2021-2031

Figure 60: Eastern Europe Drug of Abuse Testing Market Attractiveness Analysis by End User, 2021-2031

Figure 61: Eastern Europe Drug of Abuse Testing Market Attractiveness Analysis by Country, 2021-2031

Figure 62: APEJ Drug of Abuse Testing Market Value Share, By Drug Type (2021 E)

Figure 63: APEJ Drug of Abuse Testing Market Value Share, By Technique (2021 E)

Figure 64: APEJ Drug of Abuse Testing Market Value Share, By End User (2021 E)

Figure 65: APEJ Drug of Abuse Testing Market Value Share, By Country (2021 E)

Figure 66: APEJ Drug of Abuse Testing Market Value Analysis (US$ Mn), 2016-2020

Figure 67: APEJ Drug of Abuse Testing Market Value Forecast (US$ Mn), 2021-2031

Figure 68: APEJ Drug of Abuse Testing Market Attractiveness Analysis by Drug Type, 2021-2031

Figure 69: APEJ Drug of Abuse Testing Market Attractiveness Analysis by Technique, 2021-2031

Figure 70: APEJ Drug of Abuse Testing Market Attractiveness Analysis by End User, 2021-2031

Figure 71: APEJ Drug of Abuse Testing Market Attractiveness Analysis by Country, 2021-2031

Figure 72: Japan Drug of Abuse Testing Market Value Share, By Drug Type (2021 E)

Figure 73: Japan Drug of Abuse Testing Market Value Share, By Technique (2021 E)

Figure 74: Japan Drug of Abuse Testing Market Value Share, By End User (2021 E)

Figure 75: Japan Drug of Abuse Testing Market Value Share, By Country (2021 E)

Figure 76: Japan Drug of Abuse Testing Market Value Analysis (US$ Mn), 2016-2020

Figure 77: Japan Drug of Abuse Testing Market Value Forecast (US$ Mn), 2021-2031

Figure 78: Japan Drug of Abuse Testing Market Attractiveness Analysis by Drug Type, 2021-2031

Figure 79: Japan Drug of Abuse Testing Market Attractiveness Analysis by Technique, 2021-2031

Figure 80: Japan Drug of Abuse Testing Market Attractiveness Analysis by End User, 2021-2031

Figure 81: Japan Drug of Abuse Testing Market Attractiveness Analysis by Country, 2021-2031

Figure 82: MEA Drug of Abuse Testing Market Value Share, By Drug Type (2021 E)

Figure 83: MEA Drug of Abuse Testing Market Value Share, By Technique (2021 E)

Figure 84: MEA Drug of Abuse Testing Market Value Share, By End User (2021 E)

Figure 85: MEA Drug of Abuse Testing Market Value Share, By Country (2021 E)

Figure 86: MEA Drug of Abuse Testing Market Value Analysis (US$ Mn), 2016-2020

Figure 87: MEA Drug of Abuse Testing Market Value Forecast (US$ Mn), 2021-2031

Figure 88: MEA Drug of Abuse Testing Market Attractiveness Analysis by Drug Type, 2021-2031

Figure 89: MEA Drug of Abuse Testing Market Attractiveness Analysis by Technique, 2021-2031

Figure 90: MEA Drug of Abuse Testing Market Attractiveness Analysis by End User, 2021-2031

Figure 91: MEA Drug of Abuse Testing Market Attractiveness Analysis by Country, 2021-2031

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Cystatin C Testing Market

Published : March 2022

Healthcare

Road Side Drug Testing Devices Market

Published : September 2019

Healthcare

Drug Testing Systems Market

Published : February 2019

Healthcare

Sports Drug Testing Market

Published : January 2019

Google translate

Drug of Abuse Testing Market